Should 'typical', first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?

Eur Arch Psychiatry Clin Neurosci. 2021 Dec;271(8):1411-1413. doi: 10.1007/s00406-021-01335-y.

Stefan Leucht¹, Maximilian Huhn², John M Davis^{3

4}

¹ Section for Evidence Based Medicine in Psychiatry and Psychotherapy, Department of Psychiatry and Psychotherapy, Technical University of Munich, School of Medicine, Ismaninger Straße. 22, 81675, Munich, Germany. stefan.leucht@tum.de.
² Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Social Foundation Bamberg, Teaching Hospital of the University of Erlangen, Erlangen, Germany.
³ Psychiatric Institute, University of Illinois at Chicago, Chicago, IL, USA.
⁴ Department of Psychiatry, John Hopkins University, Baltimore, MD, USA.

No abstract available

Publication types